Respiratory cancer and exposure to arsenic, chromium, nickel, and polycyclic aromatic hydrocarbons

Clinics in Occupational and Environmental Medicine

Volumn 2, Issue 4, 2002, Pages 779-801

  Alberg, Anthony J ^a   Yung, Rex C ^b   Strickland, Paul ^a   Nelson, Jonas ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXYPYRENE; ARSENIC; BIOLOGICAL MARKER; CHROMIUM; COKE; INSECTICIDE; NICKEL; PESTICIDE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE;

BIOLOGICAL MONITORING; BLOOD ANALYSIS; CANCER RESEARCH; CANCER RISK; CHEMICAL CARCINOGENESIS; DNA ADDUCT; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; EPIDEMIOLOGICAL DATA; GENE INTERACTION; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; INDUSTRIAL WORKER; LUNG CANCER; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; OCCUPATIONAL SAFETY; QUANTITATIVE ANALYSIS; REVIEW; URINALYSIS; WORKPLACE;

EID: 0041922326     PISSN: 15260046     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0046(02)00056-0     Document Type: Review

References (155)

1. Vineis P, Thomas T, Hayes RB, Blot WJ, Mason TJ, Pickle LW, et al. Proportion of lung cancers in males, due to occupation, in different areas of the USA. Int J Cancer 1988;42(6):851-6.
2. Steenland K, Loomis D, Shy C, Simonsen N. Review of occupational lung carcinogens. Am J Ind Med 1996;29(5):474-90.
3. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. New York: Oxford University Press; 1981. p. 1198-244.
4. Pinto SS, Henderson V, Enterline PE. Mortality experience of arsenic-exposed workers. Arch Environ Health 1978;33(6):325-31.
5. Peto R, Lopez AD, Boreham J, Thun M, Heath C. Mortality from smoking in developed countries, 1950-2000: indirect estimates from national vital statistics. New York: Oxford University Press; 1994.
6. Neubauer O. Arsenical cancer: a review. Br J Cancer 1947;1:192-244.
7. Lee AM, Fraumeni Jr JF. Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst 1969;42(6):1045-52.
8. Lee-Feldstein A. Arsenic and respiratory cancer in humans: follow-up of copper smelter employees in Montana. J Natl Cancer Inst 1983;70(4):601-10.
9. Lubin JH, Pottern, LM, Stone BJ, Fraumeni Jr JF. Respiratory cancer in a cohort of copper smelter workers: results from more than 50 years of follow-up. Am J Epidemiol 2000;151(6):554-65.
10. Viren J, Silvers A. Nonlinearity in the lung cancer dose-response for airborne arsenic: apparent confounding by year of hire in evaluating lung cancer risks from arsenic exposure in Tacoma smelter workers. Regul Toxicol Pharmacol 1999;30(2, Pt 1):117-29.
11. Pinto SS, Wash T, Bennett BM. Effect of arsenic trioxide exposure on mortality. Arch Environ Health 1963;7:89-97.
12. Enterline PE, Henderson VL, Marsh GM. Exposure to arsenic and respiratory cancer. A reanalysis. Am J Epidemiol 1987;125(6):929-38.
13. Axelson O, Dahlgren E, Jansson CD, Rehnlund SO. Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter. Br J Ind Med 1978;35(1):8-15.
14. Pershagen G, Wall S, Taube A, Linnman L. On the interaction between occupational arsenic exposure and smoking and its relationship to lung cancer. Scand J Work Environ Health 1981; 7(4):302-9.
15. Sandstrom A, Wall S. Cancer incidence among male salaried employees at a smeltery in northern Sweden. Acta Oncol 1993;32(1):9-14.
16. Hertz-Picciotto I, Smith AH. Observations on the dose-response curve for arsenic exposure and lung cancer. Scand J Work Environ Health 1993;19(4):217-26.
17. Rencher AC, Carter MW, McKee DW. A retrospective epidemiological study of mortality at a large western copper smelter. J Occup Med 1977;19(11):754-8.
18. Kuratsune M, Tokudome S, Shirakusa T, Yoshida M, Tokumitsu Y. Occupational lung cancer among copper smelters. Int J Cancer 1974;13(4):552-8.
19. Tokudome S, Kuratsune M. A cohort study on mortality from cancer and other causes among workers at a metal refinery. Int J Cancer 1976;17(3):310-7.
20. Enterline PE, Marsh GM, Esmen NA, Henderson VL, Callahan CM, Paik M. Some effects of cigarette smoking, arsenic, and SO2 on mortality among US copper smelter workers. J Occup Med 1987;29(10):831-8.
21. Welch K, Higgins I, Oh M, Burchfiel C. Arsenic exposure, smoking, and respiratory cancer in copper smelter workers. Arch Environ Health 1982;37(6):325-35.
22. Higgins I, Welch K, Oh M, Bond G, Hurwitz P. Influence of arsenic exposure and smoking on lung cancer among smelter workers: a pilot study. Am J Ind Med 1981;2(1):33-41.
23. Jarup L, Pershagen G. Arsenic exposure, smoking, and lung cancer in smelter workers - a case-control study. Am J Epidemiol 1991;134(6):545-51.
24. Hertz-Picciotto I, Holtzman DA. Issues in conducting a cancer risk assessment using epidemiologic data: arsenic as a case study. Exp Pathol 1989;37(1-4):219-23.
25. Osburn HS. Cancer of the lung in Gwanda. Cent Afr J Med 1957;3(6):215-23.
26. Osburn HS. Lung cancer in a mining district in Rhodesia. S Afr Med J 1969;43(43):1307-12.
27. Taylor PR, Qiao YL, Schatzkin A, Yao SX, Lubin J, Mao BL, et al. Relation of arsenic exposure to lung cancer among tin miners in Yunnan Province, China. Br J Ind Med 1989; 46(12):881-6.
28. Hazelton WD, Luebeck EG, Heidenreich WF, Moolgavkar SH. Analysis of a historical cohort of Chinese tin miners with arsenic, radon, cigarette smoke, and pipe smoke exposures using the biologically based two-stage clonal expansion model. Radiat Res 2001; 156(1):78-94.
29. Kusiak RA, Springer J, Ritchie AC, Muller J. Carcinoma of the lung in Ontario gold miners: possible etiological factors. Br J Ind Med 1991;48(12):808-17.
30. Kusiak RA, Ritchie AC, Muller J, Springer J. Mortality from lung cancer in Ontario uranium miners. Br J Ind Med 1993;50(10):920-8.
31. Chen R, Wei L, Huang H. Mortality from lung cancer among copper miners. Br J Ind Med 1993;50(6):505-9.
32. Simonato L, Moulin JJ, Javelaud B, Ferro G, Wild P, Winkelmann R, et al. A retrospective mortality study of workers exposed to arsenic in a gold mine and refinery in France. Am J Ind Med 1994;25(5):625-33.
33. Tomasek L, Darby SC, Fearn T, Swerdlow AJ, Placek V, Kunz E. Patterns of lung cancer mortality among uranium miners in West Bohemia with varying rates of exposure to radon and its progeny. Radiat Res 1994;137(2):251-61.
34. Hill AB, Faning EL. Studies in the incidence of cancer in a factory handling inorganic compounds of arsenic. Brit J Industr Med 1948;5(1):1-15.
35. Ott MG, Holder BB, Gordon HL. Respiratory cancer and occupational exposure to arsenicals. Arch Environ Health 1974;29(5):250-5.
36. Mabuchi K, Lilienfeld AM, Snell LM. Cancer and occupational exposure to arsenic: a study of pesticide workers. Prev Med 1980;9(1):51-77.
37. Sobel W, Bond GG, Baldwin CL, Ducommun DJ. An update of respiratory cancer and occupational exposure to arsenicals. Am J Ind Med 1988;13(2):263-70.
38. Miller CS, Hoover WL, Culver WH. Exposure of pesticide applicators to arsenic acid. Arch Environ Contam Toxicol 1980;9(3):281-8.
39. Nelson WC, Lykins MH, Mackey J, Newill VA, Finklea JF, Hammer DI. Mortality among orchard workers exposed to lead arsenate spray: a cohort study. J Chronic Dis 1973;26(2):105-18.
40. Wicklund KG, Daling JR, Allard J, Weiss NS. Respiratory cancer among orchardists in Washington State, 1968 to 1980. J Occup Med 1988;30(7):561-4.
41. Tollestrup K, Daling JR, Allard J. Mortality in a cohort of orchard workers exposed to lead arsenate pesticide spray. Arch Environ Health 1995;50(3):221-9.
42. Hill AB. Observation and experiment. N Engl J Med 1953;248(24):995-1001.
43. Basu A, Mahata J, Gupta S, Giri AK. Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat Res 2001;488(2):171 -94.
44. Simeonova PP, Luster MI. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? J Environ Pathol Toxicol Oncol 2000;19(3):281-6.
45. Langard S. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am J Ind Med 1990;17(2):189-215.
46. Mastromatteo E. Nickel: a review of its occupational health aspects. J Occup Med 1967;9(3):127-36.
47. Singh J, Carlisle DL, Pritchard DE, Patierno SR. Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). Oncol Rep 1998;5(6):1307-18.
48. Kasprzak KS. Possible role of oxidative damage in metal-induced carcinogenesis. Cancer Invest 1995;13(4):411-30.
49. Cohen MD, Kargacin B, Klein CB, Costa M. Mechanisms of chromium carcinogenicity and toxicity. Crit Rev Toxicol 1993;23(3):255-81.
50. Gibb H, Chen C. Evaluation of issues relating to the carcinogen risk assessment of chromium. Sci Total Environ 1989;86(1-2):181-6.
51. De Flora S. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis 2000;21(4):533-41.
52. Baetjer AM. Pulmonary carcinoma in chromate workers. AMA Arch Ind Hyg Occup Med 1950;2:505-16.
53. Bidstrup PL, Case RAM. Carcinoma of the lung in workmen in the biochromates-producing industry in Great Britain. Brit J Industr Med 1956;13:260-4.
54. Brinton HP, Frasier ES, Koven AL. Morbidity and mortality experience among chromate workers. Public Health Rep 1952;67:835-47.
55. Machle W, Gregorius F. Cancer of the respiratory system in the United States chromate-producing industry. Public Health Rep 1948;63:1114-27.
56. Mancuso TF, Hueper WC. Occupational cancer and other health hazards in a chromate plant: a medical appraisal. Ind Med Surg 1951;20:358-63.
57. Alderson MR, Rattan NS, Bidstrup L. Health of workmen in the chromate-producing industry in Britain. Br J Ind Med 1981;38(2):117-24.
58. Hayes RB, Lilienfeld AM, Snell LM. Mortality in chromium chemical production workers: a prospective study. Int J Epidemiol 1979;8(4):365-74.
59. Mancuso TF. Chromium as an industrial carcinogen. Part I. Am J Ind Med 1997;31(2):129-39.
60. Taylor FH. The relationship of mortality and duration of employment as reflected by a cohort of chromate workers. Am J Public Health Nations Health 1966;56(2):218-22.
61. Satoh K, Fukuda Y, Torii K, Katsuno N. Epidemiological study of workers engaged in the manufacture of chromium compounds. J Occup Med 1981;23(12):835-8.
62. Enterline PE. Respiratory cancer among chromate workers. J Occup Med 1974;16(8):523-6.
63. Davies JM, Easton DF, Bidstrup PL. Mortality from respiratory cancer and other causes in United Kingdom chromate production workers. Br J Ind Med 1991;48(5):299-313.
64. Hayes RB. Review of occupational epidemiology of chromium chemicals and respiratory cancer. Sci Total Environ 1988;71(3):331-9.
65. Langard S, Vigander T. Occurrence of lung cancer in workers producing chromium pigments. Br J Ind Med 1983;40(1):71-4.
66. Hayes RB, Sheffet A, Spirtas R. Cancer mortality among a cohort of chromium pigment workers. Am J Ind Med 1989;16(2):127-33.
67. Frentzel-Beyme R. Lung cancer mortality of workers employed in chromate pigment factories. A multicentric European epidemiological study. J Cancer Res Clin Oncol 1983;105(2):183-8.
68. Deschamps F, Moulin JJ, Wild P, Labriffe H, Haguenoer JM. Mortality study among workers producing chromate pigments in France. Int Arch Occup Environ Health 1995;67(3):147-52.
69. Davies JM. Lung cancer mortality among workers making lead chromate and zinc chromate pigments at three English factories. Br J Ind Med 1984;41(2):158-69.
70. Kano K, Horikawa M, Utsunomiya T, Tati M, Satoh K, Yamaguchi S. Lung cancer mortality among a cohort of male chromate pigment workers in Japan. Int J Epidemiol 1993;22(1):16-22.
71. Dalager NA, Mason TJ, Fraumeni Jr JF, Hoover R, Payne WW. Cancer mortality among workers exposed to zinc chromate paints. J Occup Med 1980;22(1):25-9.
72. Alexander BH, Checkoway H, Wechsler L, Heyer NJ, Muhm JM, O'Keeffe TP. Lung cancer in chromate-exposed aerospace workers. J Occup Environ Med 1996;38(12):1253-8.
73. Okubo T, Tsuchiya K. Epidemiological study of chromium platers in Japan. Biol Trace Elem Res 1979;1:35-44.
74. Horiguchi S, Morinaga K, Endo G. Epidemiological study of mortality from cancer among chromium platers. Asia Pac J Public Health 1990;4(2-3):169-74.
75. Takahashi K, Okubo T. A prospective cohort study of chromium plating workers in Japan. Arch Environ Health 1990;45(2):107-11.
76. Sorahan T, Burges DC, Hamilton L, Harrington JM. Lung cancer mortality in nickel/chromium platers, 1946-95. Occup Environ Med 1998;55(4):236-42.
77. Sorahan T, Harrington JM. Lung cancer in Yorkshire chrome platers, 1972-97. Occup Environ Med 2000;57(6):385-9.
78. Silverstein M, Mirer F, Kotelchuck D, Silverstein B, Bennett M. Mortality among workers in a die-casting and electroplating plant. Scand J Work Environ Health 1981;7(Suppl 4):156-65.
79. Franchini I, Magnani F, Mutti A. Mortality experience among chromeplating workers. Initial findings. Scand J Work Environ Health 1983;9(3):247-52.
80. Axelsson G, Rylander R, Schmidt A. Mortality and incidence of tumours among ferrochromium workers. Br J Ind Med 1980;37(2):121-7.
81. Langard S, Andersen A, Gylseth B. Incidence of cancer among ferrochromium and ferrosilicon workers. Br J Ind Med 1980;37(2):114-20.
82. Sjogren B, Gustavsson A, Hedstrom L. Mortality in two cohorts of welders exposed to high- and low-levels of hexavalent chromium. Scand J Work Environ Health 1987;13(3):247-51.
83. Ewis AA, Kondo K, Lee J, Tsuyuguchi M, Hashimoto M, Yokose T, et al. Occupational cancer genetics: infrequent ras oncogenes point mutations in lung cancer samples from chromate workers. Am J Ind Med 2001;40(1):92-7.
84. Gao M, Levy LS, Faux SP, Aw TC, Braithwaite RA, Brown SS. Use of molecular epidemiological techniques in a pilot study on workers exposed to chromium. Occup Environ Med 1994;51(10):663-8.
85. Kim H, Cho SH, Chung MH. Exposure to hexavalent chromium does not increase 8-hydroxydeoxyguanosine levels in Korean chromate pigment workers. Ind Health 1999; 37(3):335-41.
86. Korallus U, Ulm K, Steinmann-Steiner-Haldenstaett W. Bronchial carcinoma mortality in the German chromate-producing industry: the effects of process modification. Int Arch Occup Environ Health 1993;65(3):171-8.
87. Sunderman Jr FW. Recent research on nickel carcinogenesis. Environ Health Perspect 1981; 40:131-41.
88. Hartwig A, Mullenders LH, Schlepegrell R, Kasten U, Beyersmann D. Nickel(II) interferes with the incision step in nucleotide excision repair in mammalian cells. Cancer Res 1994; 54(15):4045-51.
89. Zienolddinyl S, Svendsrud DH, Ryberg D, Mikalsen AB, Haugen A. Nickel(II) induces microsatellite mutations in human lung cancer cell lines. Mutat Res 2000;452(1):91-100.
90. Report of the International Committee on Nickel Carcinogenesis in Man. Scand J Work Environ Health 1990;16(1):1-82.
91. Anttila A, Pukkala E, Aitio A, Rantanen T, Karjalainen S. Update of cancer incidence among workers at a copper/nickel smelter and nickel refinery. Int Arch Occup Environ Health 1998; 71(4):245-50.
92. Jarup L, Bellander T, Hogstedt C, Spang G. Mortality and cancer incidence in Swedish battery workers exposed to cadmium and nickel. Occup Environ Med 1998;55(11):755-9.
93. Bostrom CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, Kyrklund T, et al. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 2002;110(Suppl 3):451-88.
94. Boffetta P, Jourenkova N, Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 1997;8(3):444-72.
95. Smith LE, Denissenko MF, Bennett WP, Li H, Amin S, Tang M, et al. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J Natl Cancer Inst 2000; 92(10):803-11.
96. Rubin H. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis 2001;22(12):1903-30.
97. Doll R. The causes of death among gas-workers with special reference to cancer of the lung. Brit J Industr Med 1952;9:180-5.
98. Doll R, Fisher REW, Gammon EJ, Gunn W, Hughes GO, Tyrer FH, et al. Mortality of gas workers with special reference to cancers of the lung and bladder, chronic bronchitis, and pneumoconiosis. Brit J Industr Med 1965;22:1-12.
99. Doll R, Vessey MP, Beasley RWR, Buckley AR, Fear EC, Fisher REW, et al. Mortality of gasworkers-final report of a prospective study. Br J Ind Med 1972;29:394-406.
100. Armstrong B, Tremblay C, Baris D, Theriault G. Lung cancer mortality and polynuclear aromatic hydrocarbons: a case-cohort study of aluminum production workers in Arvida, Quebec, Canada. Am J Epidemiol 1994;139(3):250-62.
101. Andersen A, Dahlberg BE, Magnus K, Wannag A. Risk of cancer in the Norwegian aluminium industry. Int J Cancer 1982;29(3):295-8.
102. Gibbs GW. Mortality of aluminum reduction plant workers, 1950 through 1977. J Occup Med 1985;27(10):761-70.
103. Ronneberg A, Haldorsen T, Romundstad P, Andersen A. Occupational exposure and cancer incidence among workers from an aluminum smelter in western Norway. Scand J Work Environ Health 1999;25(3):207-14.
104. Romundstad P, Haldorsen T, Andersen A. Lung and bladder cancer among workers in a Norwegian aluminium reduction plant. Occup Environ Med 2000;57(7):495-9.
105. Rockette HE, Arena VC. Mortality studies of aluminum reduction plant workers: potroom and carbon department. J Occup Med 1983;25(7):549-57.
106. Mur JM, Moulin JJ, Meyer-Bisch C, Massin N, Coulon JP, Loulergue J. Mortality of aluminium reduction plant workers in France. Int J Epidemiol 1987;16(2):257-64.
107. Steenland K, Deddens J, Stayner L. Diesel exhaust and lung cancer in the trucking industry: exposure-response analyses and risk assessment. Am J Ind Med 1998;34(3):220-8.
108. Steenland NK, Silverman DT, Hornung RW. Case-control study of lung cancer and truck driving in the Teamsters Union. Am J Public Health 1990;80(6):670-4.
109. Boffetta P, Harris RE, Wynder EL. Case-control study on occupational exposure to diesel exhaust and lung cancer risk. Am J Ind Med 1990;17(5):577-91.
110. Hayes RB, Thomas T, Silverman DT, Vineis P, Blot WJ, Mason TJ, et al. Lung cancer in motor exhaust-related occupations. Am J Ind Med 1989;16(6):685-95.
111. Gustavsson P, Plato N, Lidstrom EB, Hogstedt C. Lung cancer and exposure to diesel exhaust among bus garage workers. Scand J Work Environ Health 1990;16(5):348-54.
112. Woskie SR, Smith TJ, Hammond SK, Schenker MB, Garshick E, Speizer FE. Estimation of the diesel exhaust exposures of railroad workers: II. National and historical exposures. Am J Ind Med 1988;13(3):395-404.
113. Garshick E, Schenker MB, Munoz A, Segal M, Smith TJ, Woskie SR, et al. A case-control study of lung cancer and diesel exhaust exposure in railroad workers. Am Rev Respir Dis 1987; 135(6):1242-8.
114. Garshick E, Schenker MB, Munoz A, Segal M, Smith TJ, Woskie SR, et al. A retrospective cohort study of lung cancer and diesel exhaust exposure in railroad workers. Am Rev Respir Dis 1988;137(4):820-5.
115. Larkin EK, Smith TJ, Stayner L, Rosner B, Speizer FE, Garshick E. Diesel exhaust exposure and lung cancer: adjustment for the effect of smoking in a retrospective cohort study. Am J Ind Med 2000;38(4):399-409.
116. Lipsett M, Campleman S. Occupational exposure to diesel exhaust and lung cancer: a metaanalysis. Am J Public Health 1999;89(7):1009-17.
117. Bhatia R, Lopipero P, Smith AH. Diesel exhaust exposure and lung cancer. Epidemiology 1998;9(1):84-91.
118. Silverman DT. Is diesel exhaust a human lung carcinogen? Epidemiology 1998;9(1):4-6.
119. Stayner L, Dankovic D, Smith R, Steenland K. Predicted lung cancer risk among miners exposed to diesel exhaust particles. Am J Ind Med 1998;34(3):207-19.
120. Blot WJ, Fraumeni Jr JF. Arsenical air pollution and lung cancer. Lancet 1975;2(7926):142-4.
121. Frost F, Harter L, Milham S, Royce R, Smith AH, Hartley J, et al. Lung cancer among women residing close to an arsenic emitting copper smelter. Arch Environ Health 1987;42(3):148-52.
122. Greaves WW, Rom WN, Lyon JL, Varley G, Wright DD, Chiu G. Relationship between lung cancer and distance of residence from nonferrous smelter stack effluent. Am J Ind Med 1981; 2(1):15-23.
123. Marsh GM, Stone RA, Esmen NA, Gula MJ, Gause CK, Petersen NJ, et al. A case-control study of lung cancer mortality in four rural Arizona smelter towns. Arch Environ Health 1998;53(1):15-28.
124. Rom WN, Varley G, Lyon JL, Shopkow S. Lung cancer mortality among residents living near the El Paso smelter. Br J Ind Med 1982;39(3):269-72.
125. Rivara MI, Cebrian M, Corey G, Hernandez M, Romieu I. Cancer risk in an arsenic-contaminated area of Chile. Toxicol Ind Health 1997;13(2-3):321-38.
126. Pershagen G. Lung cancer mortality among men living near an arsenic-emitting smelter. Am J Epidemiol 1985;122(4):684-94.
127. Brown LM, Pottern LM, Blot WJ. Lung cancer in relation to environmental pollutants emitted from industrial sources. Environ Res 1984;34(2):250-61.
128. Xu ZY, Blot WJ, Xiao HP, Wu A, Feng YP, Stone BJ, et al. Smoking, air pollution, and the high rates of lung cancer in Shenyang. China. J Natl Cancer Inst 1989;81(23):1800-6.
129. Matanoski GM, Landau E, Tonascia J, Lazar C, Elliott EA, McEnroe W, et al. Cancer mortality in an industrial area of Baltimore. Environ Res 1981;25(1):8-28.
130. Cordier S, Theriault G, Iturra H. Mortality patterns in a population living near a copper smelter. Environ Res 1983;31(2):311-22.
131. Hughes JP, Polissar L, van Belle G. Evaluation and synthesis of health effects studies of communities surrounding arsenic producing industries. Int J Epidemiol 1988;17(2):407-13.
132. Axelsson G, Rylander R. Environmental chromium dust and lung cancer mortality. Environ Res 1980;23(2):469-76.
133. Fryzek JP, Mumma MT, McLaughlin JK, Henderson BE, Blot WJ. Cancer mortality in relation to environmental chromium exposure. J Occup Environ Med 2001;43(7):635-40.
134. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111(6):1710-7.
135. Early lung cancer detection: summary and conclusions. Am Rev Respir Dis 1984;130(4):565-70.
136. Laroche C, Fairbairn I, Moss H, Pepke-Zaba J, Sharples L, Flower C, et al. Role of computed tomographic scanning of the thorax prior to bronchoscopy in the investigation of suspected lung cancer. Thorax 2000;55(5):359-63.
137. Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Chest 1997;112(2):416-22.
138. van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002; 359(9315):1388-93.
139. Wang KP, Terry PB. Transbronchial needle aspiration in the diagnosis and staging of bronchogenic carcinoma. Am Rev Respir Dis 1983;127(3):344-7.
140. Gasparini S, Ferretti M, Secchi EB, Baldelli S, Zuccatosta L, Gusella P. Integration of transbronchial and percutaneous approach in the diagnosis of peripheral pulmonary nodules or masses. Experience with 1,027 consecutive cases. Chest 1995;108(1):131-7.
141. Bilaceroglu S, Gunel O, Cagirici U, Perim K. Comparison of endobronchial needle aspiration with forceps and brush biopsies in the diagnosis of endobronchial lung cancer. Monaldi Arch Chest Dis 1997;52(1):13-7.
142. Diette GB, White Jr P, Terry P, Jenckes M, Rosenthal D, Rubin HR. Utility of on-site cytopathology assessment for bronchoscopic evaluation of lung masses and adenopathy. Chest 2000;117(4):1186-90.
143. Miyazu Y, Miyazawa T, Kurimoto N, Iwamoto Y, Kanoh K, Kohno N. Endobronchial ultrasonography in the assessment of centrally located early-stage lung cancer before photodynamic therapy. Am J Respir Crit Care Med 2002;165(6):832-7.
144. Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165(4):508-13.
145. Kaneko M, Kusumoto M, Kobayashi T, Moriyama N, Naruke T, Ohmatsu H, et al. Computed tomography screening for lung carcinoma in Japan. Cancer 2000;89(11, Suppl):2485-8.
146. Henschke CI, Naidich DP, Yankelevitz DF, McGuinness G, McCauley DI, Smith JP, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer 2001;92(1):153-9.
147. Nelems JM, McEwan JD, Thompson DW, Walker GR, Pearson FG. Detection, localization, and treatment of occult bronchogenic carcinoma in nickel workers. J Thorac Cardiovasc Surg 1979; 77(4):522-5.
148. Qiao YL, Tockman MS, Li L, Erozan YS, Yao SX, Barrett MJ, et al. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China. Cancer Epidemiol Biomarkers Prev 1997;6(11):893-900.
149. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002;62(8):2370-7.
150. Tian D, Ma H, Feng Z, Xia Y, Le XC, Ni Z, et al. Analyses of micronuclei in exfoliated epithelial cells from individuals chronically exposed to arsenic via drinking water in inner Mongolia. China. J Toxicol Environ Health A 2001;64(6):473-84.
151. Palcic B, Garner DM, Beveridge J, Sun XR, Doudkine A, MacAulay C, et al. Increase of sensitivity of sputum cytology using high-resolution image cytometry: Field study results. Cytometry 2002;50(3):168-76.
152. Hartwig A, Schwerdtle T. Interactions by carcinogenic metal compounds with DNA repair processes: toxicological implications. Toxicol Lett 2002;127(1-3):47-54.
153. Miller III MC, Mohrenweiser HW, Bell DA. Genetic variability in susceptibility and response to toxicants. Toxicol Lett 2001;120(1-3):269-80.
154. McAughey JJ, Samuel AM, Baxter PJ, Smith NJ. Biological monitoring of occupational exposure in the chromate pigment production industry. Sci Total Environ 1988;71(3):317-22.
155. van Delft JH, Steenwinkel MS, van Asten JG, de Vogel N, Bruijntjes-Rozier TC, Schouten T, et al. Biological monitoring the exposure to polycyclic aromatic hydrocarbons of coke oven workers in relation to smoking and genetic polymorphisms for GSTM1 and GSTT1. Ann Occup Hyg 2001;45(5):395-408.